title: Clinical perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 guidelines for CYP2D6 and codeine.
authors.affiliation: Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, MN. nicholson.wayne@mayo.edu.
authors.forename: Wayne T
authors.initials: WT
authors.lastname: Nicholson
authors.affiliation: Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, MN.
authors.forename: Christine M
authors.initials: CM
authors.lastname: Formea
mesh_terms: D000701:Analgesics, Opioid / Q000378:metabolism / Q000627:therapeutic use*; D003061:Codeine / Q000378:metabolism / Q000627:therapeutic use*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D059408:Pain Management; D010597:Pharmacogenetics; D017410:Practice Guidelines as Topic
chemical_list: D000701:Analgesics, Opioid; D019389:Cytochrome P-450 CYP2D6; D003061:Codeine